0000874015-24-000178.txt : 20240717
0000874015-24-000178.hdr.sgml : 20240717
20240717170235
ACCESSION NUMBER: 0000874015-24-000178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240717
DATE AS OF CHANGE: 20240717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Diaz Allene M.
CENTRAL INDEX KEY: 0001773314
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 241122844
MAIL ADDRESS:
STREET 1: C/O ALLENA PHARMACEUTIALS, INC.
STREET 2: ONEW NEWTON EXECUTIVE PARK SUITE 202
CITY: NEWTON
STATE: MA
ZIP: 02462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330336973
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-07-15
0
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001773314
Diaz Allene M.
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
0
0
0
1
Common Stock
2024-07-15
4
M
0
4677
0.0
A
17353
D
Common Stock
2024-07-16
4
S
0
900
48.9379
D
16453
D
Common Stock
2024-07-16
4
S
0
737
50.17
D
15716
D
Restricted Stock Unit
0.0
2024-07-15
4
M
0
4677
0.0
D
Common Stock
4677
4079
D
Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 3, 2023
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.745 to $49.461 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.0825 to $50.245 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) on this Form 4.
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
By: Patrick R. O'Neil, attorney-in-fact For: Allene M. Diaz
2024-07-16